
Yicun Wu
Examiner (ID: 5533, Phone: (571)272-4087 , Office: P/2153 )
| Most Active Art Unit | 2153 |
| Art Unit(s) | 2165, 2175, 2158, 2153, 2169 |
| Total Applications | 1032 |
| Issued Applications | 828 |
| Pending Applications | 62 |
| Abandoned Applications | 165 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13000003
[patent_doc_number] => 10023659
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-17
[patent_title] => Processes for the production of chemically-modified heparins
[patent_app_type] => utility
[patent_app_number] => 14/898862
[patent_app_country] => US
[patent_app_date] => 2014-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10164
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 261
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14898862
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/898862 | Processes for the production of chemically-modified heparins | Jun 18, 2014 | Issued |
Array
(
[id] => 10812105
[patent_doc_number] => 20160158265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'ISOLATION OF NOVEL BIOACTIVE COMPOUND OBTAINED FROM OIL PALM BASE MATERIALS'
[patent_app_type] => utility
[patent_app_number] => 14/900965
[patent_app_country] => US
[patent_app_date] => 2014-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3460
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14900965
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/900965 | ISOLATION OF NOVEL BIOACTIVE COMPOUND OBTAINED FROM OIL PALM BASE MATERIALS | Jun 16, 2014 | Abandoned |
Array
(
[id] => 9772508
[patent_doc_number] => 20140296171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'NOVEL UREA COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/306261
[patent_app_country] => US
[patent_app_date] => 2014-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6939
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14306261
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/306261 | NOVEL UREA COMPOUNDS | Jun 16, 2014 | Abandoned |
Array
(
[id] => 10782877
[patent_doc_number] => 20160129034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-12
[patent_title] => 'COMBINATION OF RO5503781, CAPECITABINE AND OXALIPLANTIN FOR CANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/897416
[patent_app_country] => US
[patent_app_date] => 2014-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2649
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14897416
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/897416 | COMBINATION OF RO5503781, CAPECITABINE AND OXALIPLANTIN FOR CANCER THERAPY | Jun 15, 2014 | Abandoned |
Array
(
[id] => 10782876
[patent_doc_number] => 20160129033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-12
[patent_title] => 'COMBINATION OF RO5503781 AND CAPECITABINE FOR CANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/896716
[patent_app_country] => US
[patent_app_date] => 2014-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3273
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14896716
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/896716 | COMBINATION OF RO5503781 AND CAPECITABINE FOR CANCER THERAPY | Jun 15, 2014 | Abandoned |
Array
(
[id] => 10805326
[patent_doc_number] => 20160151483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'BETA-GLYCOLIPIDS FOR USE AS ADJUVANTS'
[patent_app_type] => utility
[patent_app_number] => 14/896789
[patent_app_country] => US
[patent_app_date] => 2014-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7671
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14896789
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/896789 | BETA-GLYCOLIPIDS FOR USE AS ADJUVANTS | Jun 9, 2014 | Abandoned |
Array
(
[id] => 13013865
[patent_doc_number] => 10030040
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-24
[patent_title] => Preparation of (S,S)-secoisolariciresinol diglucoside and (R,R)-secoisolariciresinol diglucoside
[patent_app_type] => utility
[patent_app_number] => 14/897181
[patent_app_country] => US
[patent_app_date] => 2014-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10592
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14897181
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/897181 | Preparation of (S,S)-secoisolariciresinol diglucoside and (R,R)-secoisolariciresinol diglucoside | Jun 9, 2014 | Issued |
Array
(
[id] => 11813857
[patent_doc_number] => 09717790
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-01
[patent_title] => 'Sphingoglycolipid analogues'
[patent_app_type] => utility
[patent_app_number] => 14/897601
[patent_app_country] => US
[patent_app_date] => 2014-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 26771
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14897601
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/897601 | Sphingoglycolipid analogues | Jun 9, 2014 | Issued |
Array
(
[id] => 13763343
[patent_doc_number] => 10174006
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-08
[patent_title] => Topical aqueous ophthalmic compositions containing a 1H-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease
[patent_app_type] => utility
[patent_app_number] => 14/292082
[patent_app_country] => US
[patent_app_date] => 2014-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12995
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 384
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14292082
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/292082 | Topical aqueous ophthalmic compositions containing a 1H-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease | May 29, 2014 | Issued |
Array
(
[id] => 9739218
[patent_doc_number] => 20140274937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'METHODS OF TREATING HEMATOLOGIC CANCERS'
[patent_app_type] => utility
[patent_app_number] => 14/292075
[patent_app_country] => US
[patent_app_date] => 2014-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 6213
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14292075
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/292075 | METHODS OF TREATING HEMATOLOGIC CANCERS | May 29, 2014 | Abandoned |
Array
(
[id] => 10737224
[patent_doc_number] => 20160083374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-24
[patent_title] => 'AMORPHOUS FORM OF CANAGLIFLOZIN AND PROCESS FOR PREPARING THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/891654
[patent_app_country] => US
[patent_app_date] => 2014-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5112
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14891654
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/891654 | AMORPHOUS FORM OF CANAGLIFLOZIN AND PROCESS FOR PREPARING THEREOF | May 29, 2014 | Abandoned |
Array
(
[id] => 19013059
[patent_doc_number] => 11919975
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Process for producing low endotoxin chitosan
[patent_app_type] => utility
[patent_app_number] => 14/894465
[patent_app_country] => US
[patent_app_date] => 2014-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6196
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14894465
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/894465 | Process for producing low endotoxin chitosan | May 28, 2014 | Issued |
Array
(
[id] => 10774866
[patent_doc_number] => 20160121022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'PROCESS FOR PRODUCING LOW ENDOTOXIN CHITOSAN'
[patent_app_type] => utility
[patent_app_number] => 14/894473
[patent_app_country] => US
[patent_app_date] => 2014-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6513
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14894473
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/894473 | Process for producing low endotoxin chitosan | May 28, 2014 | Issued |
Array
(
[id] => 11001801
[patent_doc_number] => 20160198748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'High-Purity Steviol Glycosides'
[patent_app_type] => utility
[patent_app_number] => 14/894084
[patent_app_country] => US
[patent_app_date] => 2014-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 36697
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14894084
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/894084 | High-Purity Steviol Glycosides | May 27, 2014 | Abandoned |
Array
(
[id] => 9739223
[patent_doc_number] => 20140274942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING MODIFIED FUCANS AND METHODS RELATING THERETO'
[patent_app_type] => utility
[patent_app_number] => 14/287307
[patent_app_country] => US
[patent_app_date] => 2014-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15061
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14287307
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/287307 | PHARMACEUTICAL COMPOSITIONS COMPRISING MODIFIED FUCANS AND METHODS RELATING THERETO | May 26, 2014 | Abandoned |
Array
(
[id] => 11881015
[patent_doc_number] => 09752174
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-05
[patent_title] => 'High-purity steviol glycosides'
[patent_app_type] => utility
[patent_app_number] => 14/287837
[patent_app_country] => US
[patent_app_date] => 2014-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 69
[patent_no_of_words] => 36767
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14287837
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/287837 | High-purity steviol glycosides | May 26, 2014 | Issued |
Array
(
[id] => 10774740
[patent_doc_number] => 20160120896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'POLYSACCHARIDE COMPOSITIONS AND RELATED METHODS'
[patent_app_type] => utility
[patent_app_number] => 14/893515
[patent_app_country] => US
[patent_app_date] => 2014-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13188
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14893515
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/893515 | POLYSACCHARIDE COMPOSITIONS AND RELATED METHODS | May 26, 2014 | Abandoned |
Array
(
[id] => 10975521
[patent_doc_number] => 20140378556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'FUCOSE-CONTAINING BACTERIAL BIOPOLYMER'
[patent_app_type] => utility
[patent_app_number] => 14/275776
[patent_app_country] => US
[patent_app_date] => 2014-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8845
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14275776
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/275776 | Fucose-containing bacterial biopolymer | May 11, 2014 | Issued |
Array
(
[id] => 10767804
[patent_doc_number] => 20160113960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-28
[patent_title] => 'TOPICAL PREPARATIONS COMPRISING HYALURONIC ACID, VERBASCOSIDE AND GLYCEROPHOSPHOINOSITOL'
[patent_app_type] => utility
[patent_app_number] => 14/889894
[patent_app_country] => US
[patent_app_date] => 2014-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8505
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14889894
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/889894 | TOPICAL PREPARATIONS COMPRISING HYALURONIC ACID, VERBASCOSIDE AND GLYCEROPHOSPHOINOSITOL | May 6, 2014 | Abandoned |
Array
(
[id] => 11256076
[patent_doc_number] => 09480966
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-01
[patent_title] => 'Substrates and methods for collection, stabilization and elution of biomolecules'
[patent_app_type] => utility
[patent_app_number] => 14/261900
[patent_app_country] => US
[patent_app_date] => 2014-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5790
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14261900
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/261900 | Substrates and methods for collection, stabilization and elution of biomolecules | Apr 24, 2014 | Issued |